New guide, new endpoint: Studying hypoglycaemia for diabetic drug efficacy
The FDA draft guidance on diabetes efficacy endpoints has elicited positive response, but stakeholders and experts stress reasonability.

The FDA draft guidance on diabetes efficacy endpoints has elicited positive response, but stakeholders and experts stress reasonability.
The company aims to publish the first results from the trial next year.
The pharmaceutical industry continues to be a hotbed of innovation, with activity driven by the evolution of new treatment paradigms,...
Junshi publishes positive Phase III results for Covid-19 pill VV116
University of Queensland’s vaccine shows virus-neutralising effect in trial
AIM ImmunoTech concludes dosing in Phase II post-Covid drug trial
Why COP28 is “the most important COP” since the Paris Agreement